1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
STERIS reported fiscal 2025 third-quarter results for the quarter ended December 31, 2024, with revenue up 6% to $1.4 billion and diluted EPS from continuing operations of $1.75, up from $1.49 a year earlier. The company lowered its fiscal 2025 revenue growth expectation to about 6% from 6.5% to 7.5% and narrowed its adjusted EPS range to $9.05 to $9.15 from $9.05 to $9.25, mainly due to currency. Shareholders get stronger quarterly growth alongside a less optimistic full-year outlook.
Q3 revenue rose 6% to $1.4 billion; diluted EPS from continuing operations was $1.75 versus $1.49
Adjusted diluted EPS was $2.32 versus $2.09 in the prior-year quarter
Fiscal 2025 revenue growth now expected at about 6%, versus prior expectations of 6.5% to 7.5%
Fiscal 2025 adjusted EPS now $9.05 to $9.15, versus $9.05 to $9.25; company cites about a ten cent negative currency impact
MetLife reported fourth quarter 2024 net income of $1.2 billion, or $1.78 per share, up from $574 million, or $0.77 per share, a year earlier. Adjusted earnings per share rose 14% to $2.09, and full year adjusted earnings per share rose 12% to $8.15. The company also raised its adjusted return on equity target to 15% to 17% from 13% to 15%, set a new target of double-digit adjusted earnings per share growth, and lowered its direct expense ratio target.
Q4 2024 net income was $1.2 billion, or $1.78 per share, versus $574 million, or $0.77 per share, in Q4 2023.
Q4 2024 adjusted earnings were $1.5 billion, or $2.09 per share, versus $1.83 per share a year earlier; full year adjusted earnings per share were $8.15, up 12%.
Q4 2024 premiums, fees and other revenues were $14.5 billion, up 6% from the prior-year quarter.
Adjusted ROE target raised to 15% to 17%; direct expense ratio target lowered from 12.3% to 12.1% over the near term and 11.3% over the New Frontier period.
EnerSys reported third-quarter fiscal 2025 net sales of $906.2 million, up 5.2% from a year earlier but below its $920 million to $960 million guidance, and adjusted diluted EPS of $3.12, above its $3.00 to $3.10 guidance. The company cut its full-year net sales forecast to $3,603 million to $3,643 million from $3,675 million to $3,765 million, while raising its full-year adjusted EPS forecast to $9.97 to $10.07 from $9.65 to $9.95, and declared a $0.24 quarterly dividend.
Q3 net sales $906.2 million, up 5.2%, but below the $920 million to $960 million guidance
Q3 adjusted diluted EPS $3.12 versus $2.56 a year earlier and guidance of $3.00 to $3.10; GAAP diluted EPS $2.88
Full-year fiscal 2025 net sales guidance lowered to $3,603 million to $3,643 million; adjusted EPS guidance raised to $9.97 to $10.07
Quarterly dividend of $0.24 per share payable March 28, 2025 to holders of record as of March 14, 2025
PTC reported first-quarter fiscal 2025 revenue of $565 million, up 3% from $550 million, and GAAP EPS of $0.68 versus $0.55, while non-GAAP EPS was $1.10 versus $1.11. The company lowered its full-year fiscal 2025 revenue and EPS guidance, which matters to shareholders because the outlook for the year is now lower than previously stated.
Q1 fiscal 2025 revenue was $565 million, up 3% from $550 million; GAAP EPS was $0.68 versus $0.55 and non-GAAP EPS was $1.10 versus $1.11.
FY2025 revenue guidance was lowered to $2.43 billion to $2.53 billion from $2.505 billion to $2.605 billion.
FY2025 non-GAAP EPS guidance was lowered to $5.30 to $6.00 from $5.60 to $6.30.
Q1 operating cash flow was $238 million, up 27%, and the company repurchased $75 million of its stock.
Johnson Controls reported fiscal first quarter 2025 sales of $5.4 billion, up 4% from a year earlier and up 10% organically, with GAAP EPS of $0.55 and adjusted EPS of $0.64. The company raised its full-year fiscal 2025 adjusted EPS guidance to approximately $3.50 to $3.60 from $3.40 to $3.50, which is a higher outlook for shareholders. The same day, it named Joakim Weidemanis as its next Chief Executive Officer, effective March 12, 2025.
Q1 sales of $5.4 billion rose 4% as reported and 10% organically; GAAP income from continuing operations was $363 million
Full-year fiscal 2025 adjusted EPS guidance raised to approximately $3.50 to $3.60, from $3.40 to $3.50; adjusted segment EBITA margin improvement now more than 80 basis points, up from more than 50
Fiscal Q2 adjusted EPS guidance of approximately $0.77 to $0.79 was initiated
Joakim Weidemanis will succeed George Oliver as CEO effective March 12, 2025, after the 2025 Annual General Meeting
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.